Pharming Group N.V.
Develops and commercializes medicines for rare, debilitating, and life-threatening diseases.
PHARM | AS
Overview
Corporate Details
- ISIN(s):
- NL0010391025 (+1 more)
- LEI:
- 724500DCJ9MPG74JEH91
- Country:
- Netherlands
- Address:
- Darwinweg 24, 2333CR Leiden
- Website:
- https://www.pharming.com/
- Sector:
- Manufacturing
Description
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2011-08-04 08:23 |
Pharming publishes financial report first half year 2011
|
English | 299.9 KB | ||
| 2011-08-04 07:38 | English | 299.9 KB | |||
| 2011-07-21 08:51 |
Pharming completes a private placement raising €3.2 million
|
English | 174.3 KB | ||
| 2011-06-10 08:18 |
Granting of U.S. patent further extends protection of Pharming's core technolog…
|
English | 171.6 KB | ||
| 2011-06-07 08:16 |
Pharming signs commercialization agreement with MegaPharm for Ruconest® in Isra…
|
English | 81.8 KB | ||
| 2011-05-23 08:11 |
New data support efficacy of Ruconest across all HAE attack locations
|
English | 65.1 KB | ||
| 2011-05-12 08:13 |
Pharming announces first quarter financial report 2011
|
English | 215.9 KB | ||
| 2011-05-12 08:04 |
Pharming Annual Shareholders Meeting
|
English | 146.1 KB | ||
| 2011-05-12 07:20 | English | 215.9 KB | |||
| 2011-05-05 08:44 |
Pharming amends Phase III clinical study with Rhucin in Acute Hereditary Angioe…
|
English | 176.8 KB | ||
| 2011-03-31 09:41 | English | 1.5 MB | |||
| 2011-03-31 09:01 |
Jaarrekening 2010
|
Dutch | 1.5 MB | ||
| 2011-03-21 10:30 |
SANTARUS AND PHARMING ANNOUNCE RHUCIN POSTER AT AMERICAN ACADEMY OF ALLERGY, AS…
|
English | 179.8 KB | ||
| 2011-03-07 07:57 |
Socius exercises warrants
|
English | 148.5 KB | ||
| 2011-03-03 08:16 |
Pharming announces preliminary financial results 2010
|
English | 212.3 KB |
Automate Your Workflow. Get a real-time feed of all Pharming Group N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharming Group N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharming Group N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-24 | D.A. Jorn | Non-Executive member | Other | 7,446 | N/A |
| 2023-03-21 | P. Sekhri | Non-Executive member | Other | 9,363 | N/A |
| 2022-10-27 | P. Sekhri | Non-Executive member | Buy | 13,013 | 12,232.22 EUR |
| 2022-10-27 | M. Pykett | Non-Executive member | Buy | 9,760 | 9,174.40 EUR |
| 2022-08-04 | P. Sekhri | Non-Executive member | Buy | 13,013 | 10,000.23 EUR |
| 2022-08-04 | S. Baert | Non-Executive member | Buy | 9,760 | 7,500.36 EUR |
| 2022-05-25 | J. van der Meijs | Non-Executive member | Buy | 9,300 | 86,490,000.00 EUR |
| 2022-05-25 | P. Sekhri | Non-Executive member | Buy | 12,398 | 9,527.62 EUR |
| 2022-05-25 | M. Pykett | Non-Executive member | Buy | 9,300 | 7,146.86 EUR |
| 2022-03-24 | S. de Vries | Non-Executive member | Buy | 318,150 | 232,249.50 EUR |
Peer Companies
